Ifn-Lambda 3 Inhibits Hiv Infection Of Macrophages Through The Jak-Stat Pathway

Man-Qing Liu,Dun-Jin Zhou,Xu Wang,Wang Zhou,Li Ye,Jie-Liang Li,Yi-Zhong Wang,Wen-Zhe Ho
DOI: https://doi.org/10.1371/journal.pone.0035902
IF: 3.7
2012-01-01
PLoS ONE
Abstract:Background: Interferon lambda 3 (IFN-lambda 3) is a newly identified cytokine with antiviral activity, and its single nucleotide polymorphisms are strongly associated with the treatment effectiveness and development of chronic hepatitis C virus infection. We thus examined the potential of IFN-lambda 3 to inhibit HIV replication and the possible mechanisms of the anti-HIV action by IFN-lambda 3 in human macrophages.Principal Findings: Under different conditions (before, during, and after HIV infection), IFN-lambda 3 significantly inhibited viral replication in macrophages, which was associated with the induction of multiple antiviral cellular factors (ISG56, MxA, OAS1, A3G/F and tetherin) and IFN regulatory factors (IRF-1, 3, 5, 7 and 9). This anti-HIV action of IFN-lambda 3 could be compromised by the JAK-STAT inhibitor. In addition, IFN-lambda 3 treatment of macrophages induced the expression of toll-like receptor 3 (TLR3) and two key adaptors (MyD88 and TRIF) in type I IFN pathway activation. However, HIV infection compromised IFN-lambda 3-mediated induction of the key elements in JAK-STAT signaling pathway.Conclusions: These data indicate that IFN-lambda 3 exerts its anti-HIV function by activating JAK-STAT pathway-mediated innate immunity in macrophages. Future in vivo studies are necessary in order to explore the potential for developing IFN-lambda 3-based therapy for HIV disease.
What problem does this paper attempt to address?